Guanglin Wu

Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers

Ana M. Aparicio, Li Shen, Elsa Li Ning Tapia et al. · Clinical Cancer Research · 2015 · 290 citations · Full text

Medicine, Oncology, Urology +17

Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features

Vassiliki Tzelepi, Jiexin Zhang, Jing-Fang Lu et al. · Clinical Cancer Research · 2011 · 151 citations

Medicine, Cancer Biology, Molecular Biology +17

Tumor Suppressor 101F6 and Ascorbate Synergistically and Selectively Inhibit Non–Small Cell Lung Cancer Growth by Caspase-Independent Apoptosis and Autophagy

Shoichiro Ohtani, Arifumi Iwamaru, Wuguo Deng et al. · Cancer Research · 2007 · 73 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Tumor-specific Activation of Human Telomerase Reverses Transcriptase Promoter Activity by Activating Enhancer-binding Protein-2β in Human Lung Cancer Cells

Wuguo Deng, Gitanjali Jayachandran, Guanglin Wu et al. · Journal of Biological Chemistry · 2007 · 69 citations · Full text

Medicine, Molecular Biology, Oncology +13

Synergistic Tumor Suppression by Coexpression of <i>FUS1</i> and <i>p53</i> Is Associated with Down-regulation of Murine Double Minute-2 and Activation of the Apoptotic Protease-Activating Factor 1–Dependent Apoptotic Pathway in Human Non–Small Cell Lung Cancer Cells

Wuguo Deng, Hiroyaki Kawashima, Guanglin Wu et al. · Cancer Research · 2007 · 55 citations · Full text

Medicine, Cancer Biology, Oncology +7